The University of Notre Dame enters collaborative relationship for joint development, commercialization of medical innovations.
Notre Dame will be the first university within the Cleveland Clinic Healthcare Innovation Alliance network, which includes the largest nonprofit health care system in the mid-Atlantic, MedStar Health and its MedStar Institute for Innovation; and the nation’s second-largest nonprofit, secular health care system, North Shore Long Island Jewish and its Feinstein Institute for Medical Research.
Through the Healthcare Innovation Alliance, Notre Dame will have access to Cleveland Clinic Innovations’ comprehensive technology and commercialization services infrastructure. Through streamlined integration of the various capabilities between all Alliance members, there will be a focus on the development and deployment of new medical innovations that are generated by faculty and researchers at Notre Dame.
In recent years, Notre Dame has demonstrated its commitment to strengthening its research enterprise by increasing investments in state-of-the-art facilities and infrastructure. While Notre Dame does not have a medical school, the University has grown its funded research program significantly and now secures external funding totaling more than $100 million annually. The University has invested $80 million of internal funding through its Strategic Research Investment program to advance the scope, excellence, and visibility of its research and scholarship.
With approximately 50 inventor disclosures annually, Notre Dame sees the Healthcare Innovation Alliance network as an opportunity to create a commercialization pathway for innovative technologies in the biotechnology and health science space.
“By collaborating with Cleveland Clinic Innovations, we are hoping to create marketplace opportunities for our biomedical and health innovations to be a force for good,” says Robert Bernhard, Notre Dame’s vice president for research. “We are extremely pleased to partner with Cleveland Clinic Innovations and the Alliance for the excellent complementary technology development and commercialization capabilities the alliance offers.”
Through the distinctive Healthcare Innovation Alliance, Cleveland Clinic Innovations will provide on-the-ground support to assist Notre Dame to advance the creative ideas of its researchers, faculty, and staff. Cleveland Clinic Innovations will employ the same knowledge and resources that have helped it create a reputation as an industry leader in navigating the commercialization process, resulting in 48 spin-off companies and more than 300 licensed technologies.
“Cleveland Clinic and Notre Dame share in the commitment and responsibility in identifying, developing and making innovative technologies available to extend and improve patient lives,” states Thomas Graham, M.D., chief innovations officer, Cleveland Clinic. “We are honored to have such a well-respected and prestigious organization as the first university to become a part of the Alliance network.”